CVRx, Inc. (CVRX) Operating Margin
- Operating margin · 12 months: Value -79.49%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -79.49% | Operating income / revenue. Period ending 2026-06-30. $-48.64M ÷ $61.19M × 100 ≈ -79.49% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -48.64M USD | Operating Income (Loss) |
| Revenue | 61.19M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | 12.36M USD | Research and Development Expense |
| Selling, general and administration | 89.46M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-48.64M | $61.19M | (m) | $12.36M | $89.46M | -79.49% |
| 2026-03-31 | $-49.99M | $59.07M | (m) | $11.70M | $89.20M | -84.62% |
| 2025-12-31 | $-51.27M | $56.65M | (m) | $11.13M | $88.47M | -90.49% |
| 2025-09-30 | $-50.35M | $55.97M | (m) | $10.94M | $86.70M | -89.97% |
| 2025-06-30 | $-51.10M | $54.65M | (m) | $10.29M | $86.46M | -93.50% |
| 2025-03-31 | $-50.70M | $52.87M | (m) | $10.59M | $84.22M | -95.89% |
| 2024-12-31 | $-59.49M | $51.29M | (m) | $11.13M | $91.32M | -115.98% |
| 2024-09-30 | $-58.88M | $47.26M | (m) | $10.57M | $88.08M | -124.59% |
| 2024-06-30 | $-55.39M | $44.39M | (m) | $10.76M | $82.10M | -124.78% |
| 2024-03-31 | $-53.17M | $42.09M | (m) | $11.27M | $77.44M | -126.34% |
| 2023-12-31 | $-43.10M | $39.30M | (m) | $11.63M | $64.51M | -109.69% |
| 2023-09-30 | $-44.92M | $35.17M | (m) | $12.44M | $61.60M | -127.74% |
| 2023-06-30 | $-45.52M | $30.84M | (m) | $12.04M | $58.63M | -147.59% |
| 2023-03-31 | $-44.78M | $26.37M | (m) | $11.11M | $54.66M | -169.81% |
| 2022-12-31 | $-42.53M | $22.47M | (m) | $9.95M | $50.05M | -189.27% |
| 2022-09-30 | $-39.84M | $18.95M | (m) | $8.70M | $45.61M | -210.21% |
| 2022-06-30 | $-37.00M | $16.16M | (m) | $8.11M | $41.04M | -228.97% |
| 2022-03-31 | $-31.66M | $14.25M | (m) | $8.01M | $34.18M | -222.14% |
| 2021-12-31 | $-25.97M | $13.04M | (m) | $7.50M | $27.86M | -199.20% |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $-11.51M | $6.05M | (m) | $6.41M | $9.72M | -190.22% |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |